Clinical Algorithms for the Surgical Management of Locally Recurrent Rectal Cancer

2010 ◽  
Vol 53 (9) ◽  
pp. 1248-1257 ◽  
Author(s):  
Alexander H. Mirnezami ◽  
Peter M. Sagar ◽  
Dara Kavanagh ◽  
Paul Witherspoon ◽  
Peter Lee ◽  
...  
2017 ◽  
Vol 23 (23) ◽  
pp. 4170 ◽  
Author(s):  
Daniel Jin-Keat Lee ◽  
Peter M Sagar ◽  
Gaitri Sadadcharam ◽  
Kok-Yang Tan

2012 ◽  
Vol 2012 ◽  
pp. 1-6 ◽  
Author(s):  
Niamh M. Hogan ◽  
Myles R. Joyce

Developments in chemotherapeutic strategies and surgical technique have led to improved loco regional control of rectal cancer and a decrease in recurrence rates over time. However, locally recurrent rectal cancer continues to present considerable technical challenges and results in significant morbidity and mortality. Surgery remains the only therapy with curative potential. Despite a hostile intra-operative environment, with meticulous pre-operative planning and judicious patient selection, safe surgery is feasible. The potential benefit of new techniques such as intra-operative radiotherapy and high intensity focussed ultrasonography has yet to be thoroughly investigated. The future lies in identification of predictors of recurrence, development of schematic clinical algorithms to allow standardised surgical technique and further research into genotyping platforms to allow individualisation of therapy. This review highlights important aspects of pre-operative planning, intra-operative tips and future strategies, focussing on a multimodal multidisciplinary approach.


2005 ◽  
Vol 23 (16_suppl) ◽  
pp. 3712-3712
Author(s):  
M. Yasui ◽  
M. Ikeda ◽  
Y. Fujie ◽  
T. Shingai ◽  
T. Hata ◽  
...  

Author(s):  
Rosa M. Jimenez-Rodriguez ◽  
Jonathan B. Yuval ◽  
Charles-Etienne Gabriel Sauve ◽  
Isaac Wasserman ◽  
Piyush Aggarwal ◽  
...  

BMC Cancer ◽  
2012 ◽  
Vol 12 (1) ◽  
Author(s):  
Falk Roeder ◽  
Joerg-Michael Goetz ◽  
Gregor Habl ◽  
Marc Bischof ◽  
Robert Krempien ◽  
...  

2015 ◽  
Vol 41 (3) ◽  
pp. 413-420 ◽  
Author(s):  
K. Uehara ◽  
Z. Ito ◽  
Y. Yoshino ◽  
A. Arimoto ◽  
T. Kato ◽  
...  

2021 ◽  
Author(s):  
JUNICHI SAKAMOTO ◽  
Heita Ozawa ◽  
Hiroki Nakanishi ◽  
Shin Fujita

Introduction: Given that doubling time is an indicator of tumor growth, we assessed the usefulness of carcinoembryonic antigen doubling time (CEA-DT) in prognosis prediction after curative resection for locally recurrent rectal cancer. Methods: During January 1986 to December 2016, 33 patients with locally recurrent rectal cancer who underwent curative resection at our hospital were retrospectively reviewed. The primary endpoint was the 3-year recurrence-free survival (RFS) rate. The Kaplan-Meier method was used to compare RFS rates and evaluate univariate and multivariate analyses for factors associated with oncologic outcomes, including CEA-DT. CEA-DT was classified into two groups: the short and long CEA-DT groups. Results: The 3-year overall survival and RFS rates were 62.6% and 42.4%, respectively. In multivariate analyses, CEA-DT was an independent risk factor for poor RFS. The 3-year RFS rate was significantly better in the long CEA-DT group than in the short CEA-DT group (58.8% vs. 25.0%, p = 0.0063). Conclusion: CEA-DT is a useful prognostic factor that can be assessed before surgery for locally recurrent rectal cancer. Long CEA-DT may indicate a favorable prognosis. Contrarily, short CEA-DT is associated with poor prognosis; therefore, further treatment intervention is necessary for patients with short CEA-DT.


Sign in / Sign up

Export Citation Format

Share Document